Form 4 for FHTX Foghorn Therapeutics Inc.
Accepted 2021-08-11 00:00:00 ET · period of report 2021-08-09 · accession 0001562180-21-005284 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-11 | 2021-08-09 | FHTX | Reine Allan | CFO | M - OptEx | $3.72 | +26.9K | 53.8K | +100% | +$100.0K |
| D | 2021-08-11 | 2021-08-09 | FHTX | Reine Allan | CFO | M - OptEx | $0.00 | +26.9K | 257.5K | +12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-09 | M | A | 26,892 | $3.72 | 53,784 | D | — | — | |
| 2 | Derivative | Stock Options (Right to buy) | 2021-08-09 | M | A | 26,892 | $0.00 | 257,512 | D | $3.72 · — to 2029-09-16 | 26,892 Common Stock | (F1) The option vested as to 25% of the underlying shares of common stock on September 16, 2020, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested. |